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We used a mouse fetal skin dendritic cell line (FSDC) to study the eﬀect of the strong allergen 2,4-dinitroﬂuorobenzene (DNFB)
on interleukin (IL)-1β release and IL-1β receptor immunoreactivity. Stimulation with DNFB (30 minutes) increased IL-1β release
without changing the mRNA levels of the protein. Furthermore, DNFB increased transiently the interleukin-1β-converting enzyme
(ICE) activity, as measured with its ﬂuorogenic substrate Z-Tyr-Val-Ala-Asp-AFC. The ICE inhibitor Z-YVAD-FMK prevented the
release of IL-1β evoked by DNFB. Incubation of the cells with DNFB (30 minutes) strongly increased IL-1β receptor immunoreac-
tivity. The rapid eﬀect of DNFB on the release of mature IL-1β, without inducing an increase of IL-1β mRNA in FSDC, suggests a
posttranslational modiﬁcation of pro-IL-1β by ICE activity.
INTRODUCTION
The haptens in contact with the skin bind nonspecif-
ically to a multitude of epidermal proteins becoming a
complete allergen [1]. Then, skin dendritic cells (DC),
namely, Langerhans cells (LC), the most eﬃcient antigen-
presenting cells of the epidermis, internalise the hapten-
protein immunoreactive complex, probably by endocyto-
sis [2], and process it. LC become activated, migrate to
the lymph nodes, and maturate, acquiring a functional
state favouring antigen presentation [3]. These events are
associated with the secretion of several cytokines (IL-
1β, IL-6, IL-12) [4], enhanced expression of functional
molecules (MHC-II/I complex, adhesion and costimula-
tory molecules), and altered antigen uptake, processing,
and presenting by LC [3, 5].
IL-1β is required for LC migration induced by chem-
ical allergens [6] and for the contact sensitisation process
to occur [7]. The production of this cytokine by LC in-
duces the release of various other cytokines (TNF-α,G M -
CSF, IL-1α, IL-6, and IL-10), specially from keratinocytes
(KC) [1, 4], that may also contribute to LC activation
Correspondence and reprint requests to M. Celeste Lopes, Fac-
uldade de Farm´ acia, Universidade de Coimbra, Rua do Norte,
3000-295 Coimbra, Portugal; mcﬂopes@imagem.ibili.uc.pt
and migration [4]. In mice, LC are the primary source
of IL-1β within the epidermis, and the synthesis of the
interleukin is markedly increased in contact hypersensi-
tivity [8], being produced at an early stage, 15 minutes
after the binding of a contact sensitiser IL-1β mRNA is
upregulated [8]. IL-1β knockout mice manifest impaired
contact hypersensitivity to the contact sensitiser trini-
trochlorobenzene (TNCB) [7]. Also, topical application
ofthesensitiserDNFB,dinitrochlorobenzene(DNCB),or
TNCB upregulate the level of IL-1β mRNA [8]. More-
o v e r ,i nv i t r o ,N i C l 2 and DNCB signiﬁcantly increased
IL-1β mRNA expression and IL-1β production in cul-
tured human DC [9]. Additionally, methylchloroisothia-
zolinone/methylisothiazolinone(MCI/MI)inducedIL-1β
production in monocytes [10] and DNFB, paraphenylene
diamine (PPD), and MCI/MI increased IL-1β mRNA in
human-blood-derived DC [11].
IL-1β is produced as an inert 31-kd precursor [12]
that undergoes enzymatic cleavage to a biologically active
form [13]. Conversion of pro-IL-1β into its active form is
catalysed by a cysteine protease belonging to the caspase
family, the interleukin-1β-converting enzyme (ICE) [14],
alsotermedcaspase-1[15].Intheskin,LCaretheprimary
source of ICE mRNA [16]. IL-1β can bind two receptors,
IL-1R type I (IL-1RI) and IL-1R type II (IL-1RII). IL-1β
exerts its biological eﬀects on target cells, namely on LC,
through the interaction with IL-1RI [17]. IL-1RII is not132 Teresa J. Matos et al 2005:3 (2005)
able to transduce a signal and is referred to as a decoy
receptor [18]. Therefore, regulation of IL-1 receptor ex-
pression may also have an important function in allergic
sensitisation.
In this study, we used a mouse fetal skin dendritic cell
line (FSDC), representative of early skin DC precursor
[19], to clarify some of the cellular events activated by the
sensitiser DNFB in the sensitisation phase of contact hy-
persensitivity. The results indicate that DNFB induces IL-
1R expression and that ICE is involved in DNFB-induced
IL-1β secretion in skin DC precursors.
MATERIALS AND METHODS
Reagents
The 2,4-dinitroﬂuorobenzene (DNFB) and 2,4-
dichloronitrobenzene (DCNB) were purchased from
Aldrich Chemical Company (Madrid, Spain). The
mouse recombinant GM-CSF was from Roche (Car-
naxide, Portugal). LPS from Escherichia coli (serotype
026:B26) was obtained from Sigma Chemical Co
(Madrid, Spain). The ICE inhibitor CBZ-Tyr-Val-
Ala-Asp-FMK (Z-YVAD-FMK), the ﬂuorochrome
peptide conjugated Z-Tyr-Val-Ala-Asp-7-amino-4-
triﬂuoromethylcoumarin (AFC-120), and free ﬂuo-
rochrome 7-amino-4-triﬂuoromethylcoumarin (AFC)
were purchased from Enzyme Systems Products (Liv-
ermore, Calif). The ELISA kit for mouse IL-1β was
obtained from R&D Systems (Minneapolis, Minn). The
rat anti-mouse IL-1β receptor monoclonal antibody
for immunocytochemistry was obtained from Biotrend
(Koln, Germany). The Alexa 488 goat anti-rat IgG conju-
gate and the ProLong Antifade kit were from Molecular
Probes Europe (Leiden, The Netherlands), and the nor-
mal goat serum was from Chemicon (Temecula, Calif).
Fetal calf serum was from Biochrom (Berlin, Germany)
and trypsin from Gibco Invitrogen (Paisley, UK). All
other reagents were obtained from Sigma Chemical Co.
Cellculture
The fetal mouse skin dendritic cell line, FSDC, was
kindly supplied by Dr G. Girolomoni [19]. The cells were
culturedinIscove’smodiﬁedDulbecco’smedium,supple-
mented with 36mM sodium bicarbonate, 64.4mMglu-
tamine, 10% heat-inactivated fetal calf serum, 100U/mL
penicillin, and 100µg/mL streptomycin.
Measurementofcytokineproduction
FSDCs (0.2×106 cells/well) were cultured in a 48-well
microplateandwereincubatedfor30minutesinthepres-
ence or absence of DNFB (1µg/mL), DCNB (1µg/mL),
or GM-CSF (10ng/mL), or for 12 hours in the pres-
ence of LPS (40µg/mL). For testing the eﬀect of the ICE
inhibitor Z-YVAD-FMK on IL-1β release (17-kd active
form), FSDCs were preincubated for 90 minutes with the
ICE inhibitor (100µM), prior to DNFB stimulation. In
all experiments, culture supernatants were collected and
centrifuged at 15800xg for 5 minutes to precipitate cell
debris. Samples were kept at −20◦C until used for mouse
IL-1β measurement, with an ELISA kit. Procedures were
conducted according to the manufacturer’s instructions,
which specify a detection limit of 10pg/mL and no mea-
surable cross-reactivity to other cytokines.
MeasurementofICEprotease
activityincytosolicfractions
The cells (0.8 × 106 cells/mL) were incubated with
the allergen DNFB (1µg/mL) in a 12-well microplate
for the indicated periods of time. Treated and control
cells were washed twice with ice-cold phosphate-buﬀered
saline (PBS). The cells were then lysed in 250µlo fl y -
sis buﬀer (25mM HEPES, pH 7.5, 5mM MgCl2,1m M
EDTA, and 0.1% Triton X-100), containing freshly added
1mMPMSF ,2.5µg/mL pepstatin A, and 20µg/mL ben-
zamidine. Samples were then centrifuged at 13000xg,
for 15 minutes, at 4◦C, and the supernatants were
collected and kept at −80◦C. Cleared lysates contain-
ing 40µg protein were incubated with reaction buﬀer
(50mM HEPES, 1% sucrose, and 0.1% CHAPS) con-
taining freshly added 10mM DTT, and 40µM of the en-
zyme substrate Z-Tyr-Val-Ala-Asp-AFC (AFC, 7-amino-
4-triﬂuoromethylcoumarin) for 3 hours at 37◦C. Levels
of released AFC were measured in a SPEX Fluoromax
ﬂuorometer, with excitation at 390nm and emission at
490nm. The enzyme activity was calibrated with AFC
standard solutions.
DetectionofIL-1βreceptorbyimmunocytochemistry
F S D C sw e r eg r o w no ng l a s sc o v e r s l i p s ,i n1 2 - w e l l
microplates. The cells (0.4 × 106 cells/well) were cul-
tured in the presence or absence of DNFB (1µg/mL),
for 30 minutes, as indicated in “results.” After that, FS-
DCs were ﬁxed and permeabilised by immersing the cov-
erslips in methanol:acetone (1:1), at −20◦C for 10 min-
utes. Nonspeciﬁc binding was blocked by incubation with
0.1% Tween 20/PBS, supplemented with 20% normal
goat serum, for 30 minutes at room temperature. Cells
were then incubated for 90 minutes at room temperature,
with a rat monoclonal antibody directed against both
mouse IL-1 types I (IL-1RI) and II (IL-1RII) receptors
(7.5µg/mL). After rinsing with 0.1% Tween 20/PBS, the
cells were incubated with Alexa 488-conjugated goat anti-
rat immunoglobulin (5µg/mL), in 0.1% Tween 20/PBS
supplemented with 1% normal goat serum, for 1 hour
at room temperature. The glass coverslips were rinsed
again as before and mounted with ProLong Antifade
kit onto a slide. Fluorescence labelling was visualised by
confocal microscopy, using an MRC600 confocal imag-
ing system (Bio-Rad Laboratories, Milan, Italy) linked
to a Nikon Optiphot-2 ﬂuorescence microscope. A kryp-
ton/argonmixedlaserwasusedincombinationwithaﬂu-
orescein ﬁlter to examine IL-1β receptor labelling. Image
processing included a single-medium ﬁlter pass (2×2),
using confocal assistant software (Bio-Rad Laboratories).2005:3 (2005) IL-1β a n dI C EI n d u c e db yD N F B 1 3 3
Control experiments consisted of processing the same
preparations with the omission of the primary antibody
and resulted in no speciﬁc staining.
RNAextraction
C e l l sw e r ep l a t e da t2× 106 cell/well in 6-well mi-
croplates, and grown for 24 hours. After stimulation
with DNFB for the indicated periods of time, cells were
scrapped in TRIzol Reagent (Invitrogen Life Technolo-
gies, Paisley, UK). Chloroform was added, and the sam-
ples centrifuged at 12000xg,a t4 ◦Cf o r1 5m i n u t e s ,t o
separate the phases. The aqueous phase was transferred
to a fresh tube and the RNA precipitated by mixing with
isopropylalcohol.Aftercentrifugationat12000xg,at4 ◦C
for 10 minutes, the supernatant was removed and the
RNA pellet washed with 75% ethanol. The RNA was then
resuspended in RNase-free water and stored at −80◦C.
Quantitativereal-timereversetranscription-PCR
Quantitative ﬂuorescent PCR was performed using
the TaqMan system (ABI Prism 7900HT Sequence Detec-
tion System; PE Applied Biosystems, Foster City, Calif).
Primers and TaqMan probes for mouse IL-1β and 18S
ribosomal RNA (rRNA) (used as endogenous control)
were obtained from PE Applied Biosystems. First-strand
cDNA was synthesised from total RNA using TaqMan re-
verse transcription reagents (PE Applied Biosystems), as
described by the manufacturer’s protocol. PCR for IL-1β
and 18S rRNA were performed in 25µLt o t a lr e a cti o nv o l -
umes, with 20 x Target Mix and 2 x TaqMan Universal
PCR Master Mix for IL-1β, and 200nM TaqMan probe,
50nM forward primers, 50nM reverse primers, and 2 x
TaqManUniversalPCRMasterMixfor18SrRNAendoge-
nous control (PE Applied Biosystems). Thermal cycling
was performed with 2 minutes at 50◦C for depleting con-
taminatedRNA,and10minutesdenaturationat95◦Cfol-
lowed by 40cycles at 95◦C for 15 seconds, and 1 minute
at 60◦C, using the ABI Prism 7700 detection system (PE
Applied Biosystems). The relative levels of cDNA gener-
ated from cellular RNA were calculated normalising the
amount of IL-1β cDNA relatively to 18S rRNA cDNA in
each sample.
Dataanalysis
The results are expressed as mean ± SEM of the in-
dicated number of independent experiments, and statis-
tical analysis was performed using the one-way ANOVA
test with the indicated post-test or the unpaired Student
t test, as indicated. A diﬀerence with P value less than .05
was considered statistically signiﬁcant.
RESULTS
StimulationofFSDCswithDNFBincreasesthe
releaseofIL-1βthroughICEactivation
Since LC-derived IL-1β has an important role in the
induction of contact hypersensitivity [11, 20], experi-
ments were conducted in order to determine whether the
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Figure 1. IL-1β release induced by DNFB in a fetal
skin dendritic cell line. Cells were stimulated with 2,4-
dinitroﬂuorobenzene (DNFB, 1µg/mL) or with 2,4-
dichloronitrobenzene (DCNB, 1µg/mL), for 30 minutes.
Alternatively, cells were stimulated with GM-CSF (10ng/mL)
alone, or in association with DNFB, for the same time period.
As a positive control, the cells were stimulated with LPS
(40µg/mL), for 12 hours. IL-1β was quantiﬁed with an ELISA
kit. Data express the IL-1β release above the basal secretion.
Each value represents the mean ± SEM from the indicated
number of experiments, performed in duplicate. Statistical
signiﬁcance was calculated by the one-way ANOVA test with a
Bonferroni post-test (∗∗∗ P<. 001 as compared to the control;
+++ P<. 001 as compared to stimulation with DNFB).
contact sensitiser DNFB would aﬀect IL-1β secretion in a
fetal skin dendritic cell line (FSDC). The cells were stim-
ulated with DNFB (1µg/mL), for 30 minutes, and IL-1β
concentration in culture supernatants was measured with
an ELISA kit. DNFB signiﬁcantly increased the release
of IL-1β by FSDCs (Figure 1). Preliminary experiments
showed that the concentration of DNFB (1µg/mL) and
theincubationperiodused(30minutes)producedamax-
imaleﬀectontheextracellularaccumulationofIL-1β(not
shown). In contrast with the eﬀect of DNFB, its inactive
analogue DCNB (1µg/mL) did not induce IL-1β release
(Figure 1). These results were compared with the long-
term eﬀects of LPS. When the cells were treated for 12
hours with the immunostimulatory molecule LPS, there
was also a strong induction of IL-1β secretion (Figure 1).
GM-CSF is a cytokine known to be very important
in LC progenitor diﬀerentiation, as well as in LC matu-
ration and functional regulation [21]. We have previously
shown that FSDCs express functional receptors for GM-
CSF [22]. Therefore, we also examined the eﬀect of this
cytokine on the contact-sensitiser-induced IL-1β release.
Incubation of FSDC with GM-CSF (10ng/mL) did not
cause IL-1β release and did not aﬀect the cytokine release
induced by DNFB (Figure 1).134 Teresa J. Matos et al 2005:3 (2005)
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Figure 2. Interleukin-1β-converting enzyme (ICE) protease activity and its role in DNFB-induced IL-1β release. (a) ICE protease
activity in cytosolic fractions prepared from cells incubated with DNFB (1µg/mL), for 1, 2.5, 15, or 30 minutes. Proteolytic activity in
cell lysates was measured with the caspase-1 ﬂuorogenic substrate Z-Tyr-Val-Ala-Asp-AFC, as described in “materials and methods.”
Results are represented as AFC release above basal, in pmol/mg prot/min. Basal AFC release was 324.2± 45.5pmol/mg protein/min.
Data express the mean ± SEM from the indicated number of experiments, performed in duplicate. Statistical signiﬁcance was calcu-
lated by the one-way ANOVA test with a Dunnett post-test (∗∗ P<. 01 as compared to the control). (b) IL-1β concentration in the
supernatants of fetal skin dendritic cell line. Cells were stimulated with 2,4-dinitroﬂuorobenzene (DNFB, 1µg/mL) in the presence
or absence of the interleukin-1β-converting enzyme inhibitor, Z-YVAD-FMK (100µM), for 30 minutes. In this case the cells were
preincubated with Z-YVAD-FMK (100µM), for 90 minutes. IL-1β was quantiﬁed with an ELISA kit. Data express the IL-1β release
above the basal secretion. Each value represents the mean ± SEM from the indicated number of experiments, performed in dupli-
cate. Statistical signiﬁcance was calculated by the one-way ANOVA test with a Bonferroni post-test (∗∗∗ P<. 001 as compared to the
control; +++ P<. 001 as compared to stimulation with DNFB).
In order to conﬁrm the presence of ICE enzymatic ac-
tivity that could process IL-1β for secretion, we investi-
gated the eﬀect of diﬀerent incubation times with DNFB
on AFC release from the substrate Z-Tyr-Val-Ala-Asp-
AFC. The cells were incubated for 1, 2.5, 15, or 30 min-
utes in the presence of DNFB (1µg/mL), and protease ac-
tivity was measured in the cytosolic extracts. As depicted
in Figure 2a, for the cells stimulated for 2.5 or 15 min-
utes with DNFB, a considerable increase in ICE activity
above basal was registered, whereas only a small increase
wasobservedwhentheincubationtimeswere1minuteor
30minutes,asmeasuredbytheamountofAFCgenerated.
To assess whether there was a role for interleukin-1β-
converting enzyme in the DNFB-dependent IL-1β secre-
tion, we employed Z-YVAD-FMK, a peptide inhibitor of
ICE. Based on the target sequence in pro-IL-1β (YVHD)
[23], pre-incubation of the cells with Z-YVAD-FMK, for
90 minutes, blocked almost completely DNFB-triggered
IL-1β release (Figure 2b).
StimulationofFSDCwithDNFBdoesnot
increaseIL-1βmRNAlevels
Since murine LC have been shown to produce most
of the IL-1β mRNA during activation with haptens [8],
which could account for the IL-1β release detected in this
work at 30 minutes stimulation with DNFB, we further
investigated the eﬀect of diﬀerent incubation times (5, 10,
15, 20, or 30 minutes) with DNFB in the level of IL-1β
mRNAinFSDC.IL-1β mRNAlevelwasdeterminedinto-
tal RNA extracted from cells. As shown in Figure 3,D N F B
did not modify IL-1β mRNA expression in FSDC.
DNFBincreasestheIL-1receptorimmunoreactivity
Several reports have shown LC expression of IL-1R in
murine epidermis [23, 24, 25]. Moreover, it has also been
demonstratedthatIL-1βhasanautocrineeﬀectonLC,in-
ducing its own production by LC [4, 24]. Based on these
ﬁndings, we performed subsequent experiments to ﬁnd
outwhetherthesensitiserDNFBcouldalsoberesponsible
for IL-1β autoregulatory functions in FSDC. When com-
pared with the control cells (Figure 4a), which displayed
a faint receptor immunoreactivity, cells incubated for 30
minutes with DNFB (1µg/mL) and immunostained with
an anti-IL-1R antibody that recognises both type I and
type II receptors, showed a marked increase in IL-1R im-
munoreactivity (Figure 4b). The immunoreactivity was
more evident in the perinuclear region. In contrast, GM-
CSF (10ng/mL, 12 hours) or DCNB (1µg/mL) had no2005:3 (2005) IL-1β a n dI C EI n d u c e db yD N F B 1 3 5
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Figure 3. Eﬀe c to fD N F Bo nI L - 1 β mRNA in a fetal skin den-
dritic cell line. Cells were stimulated with 1µg/mL of DNFB for
the indicated periods of time. Total RNA was then extracted us-
ing TRIzol Reagent, as described in “materials and methods,”
and cDNA was reverse transcribed from total RNA. Quantita-
tive, ﬂuorescent PCR was performed using the TaqMan system.
Relative levels of cDNA were calculated and results expressed as
fold increase relatively to the control. Data are expressed as the
mean ± SEM from the indicated number of experiments. Sta-
tistical signiﬁcance was calculated by the one-way ANOVA test
with a Dunnett post-test (no signiﬁcance was found).
signiﬁcant eﬀect on IL-1R immunoreactivity in FSDC
(data not shown). As only IL-1RI mediates the biologi-
cal activity of IL-1β, we further analysed its immunoreac-
tivity by Western blot. Comparing total extracts of con-
trol cells and cells treated with DNFB for 30 minutes, we
observed an increase in IL-1RI immunoreactivity, which
however did not reach statistical signiﬁcance (data not
shown).
DISCUSSION
A complex array of cytokines, such as IL-1β,T N F - α,
and GM-CSF, is produced by epidermal cells, namely LC
and keratinocytes (KC), during the sensitisation phase of
allergic contact dermatitis (ACD) [1]. Most data suggest a
direct eﬀect of the chemical sensitisers on LC [26, 27, 28].
However, the major cellular events involved in those pro-
cesses remain largely unknown. In the present work, we
used a murine skin-derived dendritic cell line, represen-
tative of immature LC [19], to clarify some of the mecha-
nismsinvolved intheearlyeventsofsensitisation, namely,
the mechanism involved in IL-1β secretion.
IL-1β, known to cause several modiﬁcations in
cell phenotype [20, 25], is involved in LC matura-
tion/migration during the process of sensitisation to
chemicals applied to the skin. Here, we demonstrated that
the strong sensitiser DNFB signiﬁcantly increased IL-1β
release by FSDC (Figure 1). This is in agreementwith pre-
vious studies showing that skin sensitisers induce IL-1β
release in dendritic cells and monocytes [9, 10, 11, 29].
In contrast, the nonsensitiser DCNB had no eﬀect on the
secretion of this cytokine (Figure 1), which is in agree-
ment with other studies where the use of this or other
nonsensitizers did not upregulate IL-1β protein secretion
or mRNA levels on murine epidermis [4, 8].
We also tested the eﬀects of GM-CSF on the IL-1β
secretion by FSDC, since the cytokine GM-CSF is also
known to be involved in the early stages of ACD [1]. This
cytokine, which is overproduced by KC in contact der-
matitis [30], constitute a direct or indirect inﬂammatory
stimulusforLCtomature[31].However,atleastinFSDC,
GM-CSFalone(attheconcentrationof10ng/mL)didnot
have any eﬀect on IL-1β production, neither did it signiﬁ-
cantly increase DNFB-induced IL-1β secretion (Figure 1).
Since ICE, a cytoplasmic cysteine protease, is the ma-
jor enzyme capable of generating the active and mature
form of IL-1β [14, 32] and it is known to be expressed in
murine LC cell lines and other DC [16, 33], we investi-
gated if any increase in ICE activity could be implicated
in the mechanism of action of this sensitising chemical in
FSDC. Using the ﬂuorogenic peptide substrate Z-Tyr-Val-
Ala-Asp-AFC to measure ICE activity in cytosolic extracts
of the cells incubated with DNFB, we observed that the
allergen caused a transient increase of the enzyme activ-
ity, which reached its maximum after 2.5 minutes of in-
cubation (Figure 2a). This eﬀect was already evident at
1 minute, and was sustained for 15–30 minutes. We fur-
ther investigated the role of ICE activity in the sensitiser-
evoked IL-1β release, by using a peptide inhibitor that
blocks the substrate recognition sequence of that caspase.
The eﬀect of DNFB on IL-1β release was completely abol-
ished by the ICE inhibitor (Figure 2b), strongly suggest-
ing that this enzyme is responsible for the IL-1β overpro-
duction induced by DNFB in FSDC. These results are in
agreement with those obtained in human keratinocytes
stimulated with urushiol [34], in murine macrophages
induced by ligands of macrophage scavenger receptor or
LPS [35, 36] and in microglial cells stimulated with LPS
and ATP [37]. Also, they provide evidence for an impor-
tant function of the ICE on the IL-1β secretion induced
by sensitisers and in the initiation of contact sensitivity.
Previous work by Antonopoulos et al [38] showed that
caspase-1 is needed for LC migration during skin sensiti-
sation to DNFB and oxazolone. Furthermore, in caspase-
1-deﬁcient mice there is no LC depletion after skin appli-
cation of the sensitisers and they do not develop contact
sensitivity. Also, Z-YVAD-FMK, the ICE inhibitor used in
thepresentstudy,completelypreventedLCmigrationand
contact sensitivity, in both in vivo and in vitro models.
This eﬀect may be mediated by TNF-α secreted by KC
stimulated with the sensitiser, since caspase-1 also plays
ar o l ei nT N F - α-induced LC migration [38, 39]. In our
model, lacking KC, an early induction of ICE in the pres-
ence of DNFB, rapidly followed by ICE-mediated IL-1β
release,suggestsadirecteﬀectofDNFBonDC.Thiseﬀect
of DNFB was speciﬁc, since it was not observed in the
presence of the tolerogen DCNB.
Our results indicate that DNFB stimulates the release
of IL-1β from FSDC due to stimulation of ICE activ-
ity. Although LC have been shown to upregulate IL-1β
mRNA during sensitisation [8, 11], we could not detect136 Teresa J. Matos et al 2005:3 (2005)
(a) (b)
Figure 4. Eﬀect of DNFB on IL-1R immunoreactivity. (b) IL-1R immunoreactivity in FSDCs after exposure to 2,4-
dinitroﬂuorobenzene (DNFB, 1µg/mL), for 30 minutes. (a) Control cells were maintained in medium alone. Cells were immunos-
tained with an anti-IL-1R type I and type II antibody, as described in “materials and methods.” The ﬁgures are representative of the
results obtained in three independent experiments.
any signiﬁcant increase of IL-1β mRNA upon stimula-
tion of FSDCs with DNFB (Figure 3). These results sug-
gest that, in FSDCs, the early increase of IL-1β detected is
not due to an increase in mRNA production, but rather
to ICE activation that converts existing pro-IL-1β into
mature IL-1β. Constitutive expression of IL-1β mRNA in
DC derived from human blood was reported by others
[11], and previous reports detected an increases of IL-1β
mRNA in LC, after 15 minutes of stimulation with hap-
tens [8]. Since we observed the release of IL-1β after 30
minutes of stimulation with DNFB, we only investigated
putative changes in the mRNA for the interleukin at an
early phase of stimulation. In contrast, most of the studies
thatdetectedincreaseofIL-1βmRNAexpressionandpro-
tein release focused on delayed responses (hours to days)
[9, 10, 11, 29], which cannot account for the acute eﬀect
on IL-1β release detected by us.
We also investigated the eﬀects of DNFB on the IL-
1R expression by FSDC. The biological eﬀects of IL-1 are
mediated through IL-1R type I (IL-1RI). IL-1R type II
(IL-1RII) does not appear to have a signalling function
and has been implicated in the downregulation of IL-1β
responses [8]. Murine LC cultured for one day express
the IL-1RI protein [25], and human LC present low level
of IL-1RI and high level of IL-1RII [23]. In our work,
we used a monoclonal antibody against both IL-1RI and
IL-1RII for immunocytochemistry, and we observed that
nonstimulatedFSDCpresentedlowlevelsofIL-1RI/IIim-
munoreactivity. Cell exposure to the allergen DNFB, for
30 minutes, strongly increased the IL-1RI/II immunore-
activity, mainly in the perinuclear region (Figure 4b). A
small increase in total IL-1RI protein levels (the biolog-
ically active receptor) was observed in FSDC stimulated
with DNFB, as determined by Western blot (data not
shown).
The eﬀect of DNFB on IL-1β secretion and IL-
1R immunoreactivity in FSDC (Figures 1 and 4) sug-
gests that the sensitiser-evoked IL-1β release may have
autoregulatory functions on the skin dendritic cells dur-
ing the very early phase of ACD. This conclusion is cor-
roborated by studies showing that IL-1β injection in mice
enhances its own message expression [1], providing evi-
dence for an autocrine loop.
Recently, DNFB was shown to induce a rapid activa-
tion of p38 MAPK in dendritic cells [40]. Such activation
may be involved in mediating IL-1β release observed in
thisreport,andinhumanmonocyte-derivedDC[9]stim-
ulated with contact sensitisers.
In summary, the present study suggests that, in con-
trast to the nonsensitizer DCNB, the strong contact sensi-
tiser DNFB stimulates a precocious upregulation of IL-1β
release by murine skin DC and that an increase in ICE ac-
tivity is the main mechanism involved in this release. Fur-
thermore, the observed increase in IL-1R receptors sug-
gest that the cytokine may have an autocrine eﬀect on
these DC.
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